SCOPUS 정보 검색 플랫폼

American Journal of Cardiology

Volumn 87, Issue 5 SUPPL. 1, 2001, Pages 19-22

Economics of lipid lowering in primary prevention: Lessons from the West of Scotland Coronary Prevention Study

(1) Shepherd, James a

a GLASGOW ROYAL INFIRMARY (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; SIMVASTATIN;

CARDIOVASCULAR RISK; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG SAFETY; DRUG UTILIZATION; ECONOMIC ASPECT; HEALTH CARE SYSTEM; HUMAN; PATIENT COMPLIANCE; PATIENT SELECTION; PRIMARY PREVENTION; PRIORITY JOURNAL; SECONDARY PREVENTION; UNITED KINGDOM;

EID: 0035825929 PISSN: 00029149 EISSN: None Source Type: Journal
DOI: 10.1016/S0002-9149(01)01451-5 Document Type: Conference Paper

Times cited : (21)

References (10)

1
- 0032572086
- Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS
- (1998) JAMA , vol.279 , pp. 1615-1622
- Downs, J.R.¹ Clearfield, M.² Whitney, E.³ Shapiro, D.R.⁴ Beere, P.A.⁵ Langendorfer, A.⁶ Stein, E.A.⁷ Kruyer, W.⁸ Gotto A.M., Jr.⁹

2
- 0032487931
- Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
- (1998) N Engl J Med , vol.339 , pp. 1349-1357

3
- 0342981862
- The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
- (1996) N Engl J Med , vol.335 , pp. 1001-1009
- Sacks, F.M.¹ Pfeffer, M.A.² Moye, L.A.³ Rouleau, J.L.⁴ Rutherford, J.D.⁵ Cole, T.G.⁶ Brown, L.⁷ Warnica, J.W.⁸ Arnold, J.M.O.⁹ Wun, C.-C.¹⁰ Davis, B.R.¹¹ Braunwald, E.¹²

4
- 0027987849
- Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
- (1994) Lancet , vol.344 , pp. 1383-1389

5
- 0028883828
- Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
- (1995) N Engl J Med , vol.333 , pp. 1301-1307
- Shepherd, J.¹ Cobbe, S.M.² Ford, I.³ Isles, C.G.⁴ Lorimer, A.R.⁵ Macfarlane, P.W.⁶ McKillop, J.H.⁷ Packard, C.J.⁸

6
- 0032189666
- Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other societies on coronary prevention
- (1998) Eur Heart J , vol.19 , pp. 1434-1503

7
- 0029901109
- Cost-effectiveness of cholesterol lowering: Results from the Scandinavian Simvastatin Survival Study (4S)
- (1996) Eur Heart J , vol.17 , pp. 1001-1007
- Jönsson, B.¹ Johannesson, M.² Kjekshus, J.³ Olsson, A.G.⁴ Pedersen, T.R.⁵ Wedel, H.⁶

8
- 0002321256
- Medical economics in cardiovascular medicine
- Topol EJ, ed. Philadelphia: Lippencott-Raven Publishers
- (1998) Textbook of Cardiovascular Medicine , pp. 1033-1061
- Mark, D.B.¹

9
- 0030815287
- The West of Scotland Coronary Prevention Study: Economic benefit analysis of primary prevention with pravastatin
- (1997) BMJ , vol.315 , pp. 1577-1582
- Caro, J.¹ Klittich, W.² McGuire, A.³ Ford, I.⁴ Norrie, J.⁵ Pettitt, D.⁶ McMurray, J.⁷ Shepherd, J.⁸

10
- 0001920932
- Population implications of lipid-lowering for primary prevention of coronary heart disease: Data from the 1995 Scottish Health Survey
- (1999) Heart , vol.81 , Issue.SUPPL. 1 , pp. 28
- Haq, I.U.¹ Wallis, E.J.² Yeo, W.W.³ Jackson, P.R.⁴ Ritchie, L.D.⁵ Isles, C.G.⁶ Ramsay, L.E.⁷

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.